FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. The company is headquartered in West Palm Beach, Florida and currently employs 117 full-time employees. The company went IPO on 2020-12-11. The firm owns and operates three principal subsidiaries: Rennova Community Health, Inc., which owns and operates Scott County Community Hospital, Inc., critical access designated (CAH) hospital in East Tennessee; Myrtle Recovery Centers, Inc., a 30-bed behavioral health facility in East Tennessee. The company provides inpatient services for detox and residential treatment and outpatient services for MAT and OBOT Programs, and FOXO Labs, Inc., which is a biotechnology company focused on improving human health and life span through the development of technology and product solutions for various industries. Its segments include Healthcare and Labs. The Healthcare segment offers behavioral health services, primarily substance use disorder treatments and services. The Labs segment commercializes proprietary epigenetic biomarker technology. The firm is also an information, data and biospecimen sourcing provider.
FOXO stock price ended at $0.07 on 月曜日, after dropping 12.50%
On the latest trading day Aug 10, 2026, the stock price of FOXO fell by 12.50%, dropping from $0.08 to $0.07. During the session, the stock saw a volatility of 166.67%, with prices oscillating between a daily low of $0.03 and a high of $0.08. On the latest trading day, the trading volume for FOXO rose by 7.5K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 23.7K shares were traded, with a market value of approximately $99.4K.